nodes	percent_of_prediction	percent_of_DWPC	metapath
Levorphanol—Dry mouth—Pazopanib—kidney cancer	0.00558	0.00566	CcSEcCtD
Levorphanol—Renal failure—Sunitinib—kidney cancer	0.00556	0.00564	CcSEcCtD
Levorphanol—Injection site reaction—Capecitabine—kidney cancer	0.00554	0.00562	CcSEcCtD
Levorphanol—Shock—Pazopanib—kidney cancer	0.00538	0.00546	CcSEcCtD
Levorphanol—Hypokinesia—Doxorubicin—kidney cancer	0.00532	0.0054	CcSEcCtD
Levorphanol—Hyperhidrosis—Pazopanib—kidney cancer	0.00528	0.00536	CcSEcCtD
Levorphanol—Insomnia—Temsirolimus—kidney cancer	0.00525	0.00533	CcSEcCtD
Levorphanol—Arrhythmia—Erlotinib—kidney cancer	0.00524	0.00531	CcSEcCtD
Levorphanol—Bradycardia—Sunitinib—kidney cancer	0.00517	0.00524	CcSEcCtD
Levorphanol—Muscle spasms—Everolimus—kidney cancer	0.00508	0.00516	CcSEcCtD
Levorphanol—Lethargy—Paclitaxel—kidney cancer	0.00503	0.0051	CcSEcCtD
Levorphanol—Dysuria—Vincristine—kidney cancer	0.00501	0.00509	CcSEcCtD
Levorphanol—Constipation—Temsirolimus—kidney cancer	0.00496	0.00504	CcSEcCtD
Levorphanol—Insomnia—Pazopanib—kidney cancer	0.00494	0.00502	CcSEcCtD
Levorphanol—Flushing—Sorafenib—kidney cancer	0.00489	0.00497	CcSEcCtD
Levorphanol—Agitation—Everolimus—kidney cancer	0.00486	0.00493	CcSEcCtD
Levorphanol—Abnormal vision—Capecitabine—kidney cancer	0.00486	0.00493	CcSEcCtD
Levorphanol—Mental disability—Capecitabine—kidney cancer	0.00483	0.00491	CcSEcCtD
Levorphanol—Dyspepsia—Pazopanib—kidney cancer	0.00481	0.00488	CcSEcCtD
Levorphanol—Gastrointestinal pain—Temsirolimus—kidney cancer	0.00474	0.00481	CcSEcCtD
Levorphanol—Arrhythmia—Sorafenib—kidney cancer	0.00471	0.00478	CcSEcCtD
Levorphanol—Flushing—Sunitinib—kidney cancer	0.00471	0.00478	CcSEcCtD
Levorphanol—Cardiac arrest—Paclitaxel—kidney cancer	0.00469	0.00475	CcSEcCtD
Levorphanol—Palpitations—Everolimus—kidney cancer	0.00467	0.00474	CcSEcCtD
Levorphanol—Mood swings—Paclitaxel—kidney cancer	0.00467	0.00474	CcSEcCtD
Levorphanol—Convulsion—Vinblastine—kidney cancer	0.0046	0.00467	CcSEcCtD
Levorphanol—Abdominal pain—Temsirolimus—kidney cancer	0.00459	0.00465	CcSEcCtD
Levorphanol—Sweating—Vincristine—kidney cancer	0.00458	0.00465	CcSEcCtD
Levorphanol—Convulsion—Everolimus—kidney cancer	0.00458	0.00465	CcSEcCtD
Levorphanol—Arrhythmia—Sunitinib—kidney cancer	0.00453	0.0046	CcSEcCtD
Levorphanol—Gastrointestinal pain—Pazopanib—kidney cancer	0.00447	0.00454	CcSEcCtD
Levorphanol—Renal failure—Gemcitabine—kidney cancer	0.00446	0.00452	CcSEcCtD
Levorphanol—Flushing—Dactinomycin—kidney cancer	0.00446	0.00452	CcSEcCtD
Levorphanol—Muscle spasms—Sorafenib—kidney cancer	0.00441	0.00448	CcSEcCtD
Levorphanol—Dry mouth—Everolimus—kidney cancer	0.0044	0.00447	CcSEcCtD
Levorphanol—Sweating—Gemcitabine—kidney cancer	0.00435	0.00441	CcSEcCtD
Levorphanol—Abdominal pain—Pazopanib—kidney cancer	0.00432	0.00439	CcSEcCtD
Levorphanol—Amnesia—Capecitabine—kidney cancer	0.0043	0.00437	CcSEcCtD
Levorphanol—Muscle spasms—Sunitinib—kidney cancer	0.00425	0.00431	CcSEcCtD
Levorphanol—Shock—Everolimus—kidney cancer	0.00425	0.00431	CcSEcCtD
Levorphanol—Hydromorphone—PTGS1—kidney cancer	0.00424	0.29	CrCbGaD
Levorphanol—Tachycardia—Everolimus—kidney cancer	0.00421	0.00427	CcSEcCtD
Levorphanol—Hyperhidrosis—Everolimus—kidney cancer	0.00417	0.00423	CcSEcCtD
Levorphanol—Lethargy—Capecitabine—kidney cancer	0.00413	0.00419	CcSEcCtD
Levorphanol—Pruritus—Temsirolimus—kidney cancer	0.0041	0.00417	CcSEcCtD
Levorphanol—Shock—Erlotinib—kidney cancer	0.0041	0.00416	CcSEcCtD
Levorphanol—Diplopia—Capecitabine—kidney cancer	0.00404	0.0041	CcSEcCtD
Levorphanol—Hypotension—Everolimus—kidney cancer	0.00403	0.00409	CcSEcCtD
Levorphanol—Dysuria—Paclitaxel—kidney cancer	0.00398	0.00404	CcSEcCtD
Levorphanol—Thinking abnormal—Doxorubicin—kidney cancer	0.00392	0.00398	CcSEcCtD
Levorphanol—Insomnia—Everolimus—kidney cancer	0.0039	0.00396	CcSEcCtD
Levorphanol—Pruritus—Pazopanib—kidney cancer	0.00387	0.00392	CcSEcCtD
Levorphanol—Urinary retention—Capecitabine—kidney cancer	0.00384	0.0039	CcSEcCtD
Levorphanol—Cardiac arrest—Capecitabine—kidney cancer	0.00384	0.0039	CcSEcCtD
Levorphanol—Dizziness—Temsirolimus—kidney cancer	0.00384	0.00389	CcSEcCtD
Levorphanol—Mood swings—Capecitabine—kidney cancer	0.00383	0.00389	CcSEcCtD
Levorphanol—Convulsion—Sunitinib—kidney cancer	0.00383	0.00388	CcSEcCtD
Levorphanol—Dry mouth—Sorafenib—kidney cancer	0.00382	0.00388	CcSEcCtD
Levorphanol—Dyskinesia—Doxorubicin—kidney cancer	0.00382	0.00388	CcSEcCtD
Levorphanol—Dyspepsia—Everolimus—kidney cancer	0.0038	0.00386	CcSEcCtD
Levorphanol—Insomnia—Erlotinib—kidney cancer	0.00377	0.00382	CcSEcCtD
Levorphanol—Renal failure—Paclitaxel—kidney cancer	0.00373	0.00379	CcSEcCtD
Levorphanol—Constipation—Vinblastine—kidney cancer	0.00371	0.00376	CcSEcCtD
Levorphanol—Constipation—Everolimus—kidney cancer	0.00369	0.00375	CcSEcCtD
Levorphanol—Vomiting—Temsirolimus—kidney cancer	0.00369	0.00374	CcSEcCtD
Levorphanol—Shock—Sorafenib—kidney cancer	0.00369	0.00374	CcSEcCtD
Levorphanol—Dry mouth—Sunitinib—kidney cancer	0.00368	0.00373	CcSEcCtD
Levorphanol—Dyspepsia—Erlotinib—kidney cancer	0.00367	0.00372	CcSEcCtD
Levorphanol—Rash—Temsirolimus—kidney cancer	0.00366	0.00371	CcSEcCtD
Levorphanol—Dermatitis—Temsirolimus—kidney cancer	0.00365	0.00371	CcSEcCtD
Levorphanol—Arrhythmia—Gemcitabine—kidney cancer	0.00364	0.00369	CcSEcCtD
Levorphanol—Dizziness—Pazopanib—kidney cancer	0.00361	0.00367	CcSEcCtD
Levorphanol—Feeling abnormal—Vinblastine—kidney cancer	0.00357	0.00362	CcSEcCtD
Levorphanol—Injection site reaction—Doxorubicin—kidney cancer	0.00357	0.00362	CcSEcCtD
Levorphanol—Constipation—Erlotinib—kidney cancer	0.00356	0.00361	CcSEcCtD
Levorphanol—Feeling abnormal—Everolimus—kidney cancer	0.00356	0.00361	CcSEcCtD
Levorphanol—Abnormal dreams—Doxorubicin—kidney cancer	0.00355	0.0036	CcSEcCtD
Levorphanol—Shock—Sunitinib—kidney cancer	0.00355	0.0036	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vinblastine—kidney cancer	0.00354	0.0036	CcSEcCtD
Levorphanol—Gastrointestinal pain—Everolimus—kidney cancer	0.00353	0.00358	CcSEcCtD
Levorphanol—Vomiting—Pazopanib—kidney cancer	0.00348	0.00353	CcSEcCtD
Levorphanol—Bradycardia—Paclitaxel—kidney cancer	0.00347	0.00352	CcSEcCtD
Levorphanol—Rash—Pazopanib—kidney cancer	0.00345	0.0035	CcSEcCtD
Levorphanol—Nausea—Temsirolimus—kidney cancer	0.00345	0.0035	CcSEcCtD
Levorphanol—Dermatitis—Pazopanib—kidney cancer	0.00344	0.00349	CcSEcCtD
Levorphanol—Agitation—Vincristine—kidney cancer	0.00343	0.00348	CcSEcCtD
Levorphanol—Abdominal pain—Vinblastine—kidney cancer	0.00343	0.00348	CcSEcCtD
Levorphanol—Abdominal pain—Everolimus—kidney cancer	0.00341	0.00346	CcSEcCtD
Levorphanol—Gastrointestinal pain—Erlotinib—kidney cancer	0.00341	0.00346	CcSEcCtD
Levorphanol—Dyspepsia—Sorafenib—kidney cancer	0.0033	0.00335	CcSEcCtD
Levorphanol—Abdominal pain—Erlotinib—kidney cancer	0.00329	0.00334	CcSEcCtD
Levorphanol—Visual impairment—Paclitaxel—kidney cancer	0.00329	0.00333	CcSEcCtD
Levorphanol—Coma—Doxorubicin—kidney cancer	0.00328	0.00333	CcSEcCtD
Levorphanol—Dysuria—Capecitabine—kidney cancer	0.00327	0.00332	CcSEcCtD
Levorphanol—Insomnia—Sunitinib—kidney cancer	0.00326	0.00331	CcSEcCtD
Levorphanol—Nausea—Pazopanib—kidney cancer	0.00325	0.0033	CcSEcCtD
Levorphanol—Convulsion—Vincristine—kidney cancer	0.00324	0.00329	CcSEcCtD
Levorphanol—Constipation—Sorafenib—kidney cancer	0.0032	0.00325	CcSEcCtD
Levorphanol—Dyspepsia—Sunitinib—kidney cancer	0.00317	0.00322	CcSEcCtD
Levorphanol—Flushing—Paclitaxel—kidney cancer	0.00316	0.00321	CcSEcCtD
Levorphanol—Abnormal vision—Doxorubicin—kidney cancer	0.00313	0.00318	CcSEcCtD
Levorphanol—Mental disability—Doxorubicin—kidney cancer	0.00312	0.00316	CcSEcCtD
Levorphanol—Constipation—Sunitinib—kidney cancer	0.00308	0.00313	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sorafenib—kidney cancer	0.00306	0.00311	CcSEcCtD
Levorphanol—Renal failure—Capecitabine—kidney cancer	0.00306	0.00311	CcSEcCtD
Levorphanol—Pruritus—Everolimus—kidney cancer	0.00305	0.0031	CcSEcCtD
Levorphanol—Arrhythmia—Paclitaxel—kidney cancer	0.00305	0.00309	CcSEcCtD
Levorphanol—Urticaria—Sorafenib—kidney cancer	0.00298	0.00302	CcSEcCtD
Levorphanol—Abdominal pain—Sorafenib—kidney cancer	0.00296	0.00301	CcSEcCtD
Levorphanol—Gastrointestinal pain—Sunitinib—kidney cancer	0.00295	0.00299	CcSEcCtD
Levorphanol—Hyperhidrosis—Vincristine—kidney cancer	0.00295	0.00299	CcSEcCtD
Levorphanol—Pruritus—Erlotinib—kidney cancer	0.00295	0.00299	CcSEcCtD
Levorphanol—Tension—Paclitaxel—kidney cancer	0.00291	0.00296	CcSEcCtD
Levorphanol—Nervousness—Paclitaxel—kidney cancer	0.00288	0.00292	CcSEcCtD
Levorphanol—Dizziness—Vinblastine—kidney cancer	0.00287	0.00291	CcSEcCtD
Levorphanol—Dizziness—Everolimus—kidney cancer	0.00285	0.0029	CcSEcCtD
Levorphanol—Muscle spasms—Paclitaxel—kidney cancer	0.00285	0.0029	CcSEcCtD
Levorphanol—Abdominal pain—Sunitinib—kidney cancer	0.00285	0.00289	CcSEcCtD
Levorphanol—Hypotension—Vincristine—kidney cancer	0.00285	0.00289	CcSEcCtD
Levorphanol—Bradycardia—Capecitabine—kidney cancer	0.00285	0.00289	CcSEcCtD
Levorphanol—Feeling abnormal—Dactinomycin—kidney cancer	0.00281	0.00285	CcSEcCtD
Levorphanol—Hyperhidrosis—Gemcitabine—kidney cancer	0.0028	0.00284	CcSEcCtD
Levorphanol—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00279	0.00283	CcSEcCtD
Levorphanol—Insomnia—Vincristine—kidney cancer	0.00276	0.0028	CcSEcCtD
Levorphanol—Vomiting—Vinblastine—kidney cancer	0.00275	0.0028	CcSEcCtD
Levorphanol—Dizziness—Erlotinib—kidney cancer	0.00275	0.00279	CcSEcCtD
Levorphanol—Vomiting—Everolimus—kidney cancer	0.00274	0.00278	CcSEcCtD
Levorphanol—Agitation—Paclitaxel—kidney cancer	0.00273	0.00277	CcSEcCtD
Levorphanol—Rash—Everolimus—kidney cancer	0.00272	0.00276	CcSEcCtD
Levorphanol—Dermatitis—Everolimus—kidney cancer	0.00272	0.00276	CcSEcCtD
Levorphanol—Hypotension—Gemcitabine—kidney cancer	0.0027	0.00274	CcSEcCtD
Levorphanol—Abdominal pain—Dactinomycin—kidney cancer	0.0027	0.00274	CcSEcCtD
Levorphanol—Visual impairment—Capecitabine—kidney cancer	0.0027	0.00274	CcSEcCtD
Levorphanol—Estrone—CYP1A1—kidney cancer	0.00266	0.182	CrCbGaD
Levorphanol—Lethargy—Doxorubicin—kidney cancer	0.00266	0.0027	CcSEcCtD
Levorphanol—Pruritus—Sorafenib—kidney cancer	0.00265	0.00269	CcSEcCtD
Levorphanol—Vomiting—Erlotinib—kidney cancer	0.00265	0.00269	CcSEcCtD
Levorphanol—Rash—Erlotinib—kidney cancer	0.00263	0.00266	CcSEcCtD
Levorphanol—Dermatitis—Erlotinib—kidney cancer	0.00262	0.00266	CcSEcCtD
Levorphanol—Palpitations—Paclitaxel—kidney cancer	0.00262	0.00266	CcSEcCtD
Levorphanol—Insomnia—Gemcitabine—kidney cancer	0.00262	0.00266	CcSEcCtD
Levorphanol—Constipation—Vincristine—kidney cancer	0.00261	0.00265	CcSEcCtD
Levorphanol—Diplopia—Doxorubicin—kidney cancer	0.00261	0.00265	CcSEcCtD
Levorphanol—Flushing—Capecitabine—kidney cancer	0.0026	0.00263	CcSEcCtD
Levorphanol—Nausea—Vinblastine—kidney cancer	0.00257	0.00261	CcSEcCtD
Levorphanol—Convulsion—Paclitaxel—kidney cancer	0.00257	0.00261	CcSEcCtD
Levorphanol—Affect lability—Doxorubicin—kidney cancer	0.00257	0.0026	CcSEcCtD
Levorphanol—Nausea—Everolimus—kidney cancer	0.00256	0.0026	CcSEcCtD
Levorphanol—Pruritus—Sunitinib—kidney cancer	0.00255	0.00259	CcSEcCtD
Levorphanol—Arrhythmia—Capecitabine—kidney cancer	0.0025	0.00254	CcSEcCtD
Levorphanol—Gastrointestinal pain—Vincristine—kidney cancer	0.00249	0.00253	CcSEcCtD
Levorphanol—Cardiac arrest—Doxorubicin—kidney cancer	0.00248	0.00252	CcSEcCtD
Levorphanol—Dizziness—Sorafenib—kidney cancer	0.00248	0.00251	CcSEcCtD
Levorphanol—Constipation—Gemcitabine—kidney cancer	0.00247	0.00251	CcSEcCtD
Levorphanol—Nausea—Erlotinib—kidney cancer	0.00247	0.00251	CcSEcCtD
Levorphanol—Dry mouth—Paclitaxel—kidney cancer	0.00247	0.00251	CcSEcCtD
Levorphanol—Mood swings—Doxorubicin—kidney cancer	0.00247	0.00251	CcSEcCtD
Levorphanol—Confusional state—Paclitaxel—kidney cancer	0.00244	0.00248	CcSEcCtD
Levorphanol—Abdominal pain—Vincristine—kidney cancer	0.00241	0.00245	CcSEcCtD
Levorphanol—Dizziness—Sunitinib—kidney cancer	0.00238	0.00242	CcSEcCtD
Levorphanol—Feeling abnormal—Gemcitabine—kidney cancer	0.00238	0.00242	CcSEcCtD
Levorphanol—Shock—Paclitaxel—kidney cancer	0.00238	0.00242	CcSEcCtD
Levorphanol—Vomiting—Sorafenib—kidney cancer	0.00238	0.00242	CcSEcCtD
Levorphanol—Tachycardia—Paclitaxel—kidney cancer	0.00236	0.0024	CcSEcCtD
Levorphanol—Rash—Sorafenib—kidney cancer	0.00236	0.0024	CcSEcCtD
Levorphanol—Dermatitis—Sorafenib—kidney cancer	0.00236	0.0024	CcSEcCtD
Levorphanol—Muscle spasms—Capecitabine—kidney cancer	0.00234	0.00238	CcSEcCtD
Levorphanol—Hyperhidrosis—Paclitaxel—kidney cancer	0.00234	0.00238	CcSEcCtD
Levorphanol—Vomiting—Sunitinib—kidney cancer	0.00229	0.00233	CcSEcCtD
Levorphanol—Rash—Sunitinib—kidney cancer	0.00227	0.00231	CcSEcCtD
Levorphanol—Dermatitis—Sunitinib—kidney cancer	0.00227	0.0023	CcSEcCtD
Levorphanol—Hypotension—Paclitaxel—kidney cancer	0.00226	0.0023	CcSEcCtD
Levorphanol—Nausea—Sorafenib—kidney cancer	0.00223	0.00226	CcSEcCtD
Levorphanol—Insomnia—Paclitaxel—kidney cancer	0.00219	0.00222	CcSEcCtD
Levorphanol—Vomiting—Dactinomycin—kidney cancer	0.00217	0.0022	CcSEcCtD
Levorphanol—Palpitations—Capecitabine—kidney cancer	0.00215	0.00218	CcSEcCtD
Levorphanol—Rash—Dactinomycin—kidney cancer	0.00215	0.00218	CcSEcCtD
Levorphanol—Nausea—Sunitinib—kidney cancer	0.00214	0.00217	CcSEcCtD
Levorphanol—Dyspepsia—Paclitaxel—kidney cancer	0.00213	0.00216	CcSEcCtD
Levorphanol—Dysuria—Doxorubicin—kidney cancer	0.00211	0.00214	CcSEcCtD
Levorphanol—Constipation—Paclitaxel—kidney cancer	0.00207	0.0021	CcSEcCtD
Levorphanol—Pruritus—Gemcitabine—kidney cancer	0.00205	0.00208	CcSEcCtD
Levorphanol—Dry mouth—Capecitabine—kidney cancer	0.00203	0.00206	CcSEcCtD
Levorphanol—Nausea—Dactinomycin—kidney cancer	0.00203	0.00206	CcSEcCtD
Levorphanol—Dizziness—Vincristine—kidney cancer	0.00202	0.00205	CcSEcCtD
Levorphanol—Estradiol—CYP1A1—kidney cancer	0.00202	0.138	CrCbGaD
Levorphanol—Confusional state—Capecitabine—kidney cancer	0.002	0.00203	CcSEcCtD
Levorphanol—Feeling abnormal—Paclitaxel—kidney cancer	0.002	0.00203	CcSEcCtD
Levorphanol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00198	0.00201	CcSEcCtD
Levorphanol—Renal failure—Doxorubicin—kidney cancer	0.00197	0.002	CcSEcCtD
Levorphanol—Shock—Capecitabine—kidney cancer	0.00196	0.00198	CcSEcCtD
Levorphanol—Tachycardia—Capecitabine—kidney cancer	0.00194	0.00197	CcSEcCtD
Levorphanol—Vomiting—Vincristine—kidney cancer	0.00194	0.00197	CcSEcCtD
Levorphanol—Sweating—Doxorubicin—kidney cancer	0.00193	0.00195	CcSEcCtD
Levorphanol—Urticaria—Paclitaxel—kidney cancer	0.00192	0.00195	CcSEcCtD
Levorphanol—Rash—Vincristine—kidney cancer	0.00192	0.00195	CcSEcCtD
Levorphanol—Hyperhidrosis—Capecitabine—kidney cancer	0.00192	0.00195	CcSEcCtD
Levorphanol—Dermatitis—Vincristine—kidney cancer	0.00192	0.00195	CcSEcCtD
Levorphanol—Abdominal pain—Paclitaxel—kidney cancer	0.00191	0.00194	CcSEcCtD
Levorphanol—Hypotension—Capecitabine—kidney cancer	0.00186	0.00188	CcSEcCtD
Levorphanol—Vomiting—Gemcitabine—kidney cancer	0.00184	0.00187	CcSEcCtD
Levorphanol—Bradycardia—Doxorubicin—kidney cancer	0.00184	0.00186	CcSEcCtD
Levorphanol—Rash—Gemcitabine—kidney cancer	0.00182	0.00185	CcSEcCtD
Levorphanol—Dermatitis—Gemcitabine—kidney cancer	0.00182	0.00185	CcSEcCtD
Levorphanol—Nausea—Vincristine—kidney cancer	0.00181	0.00184	CcSEcCtD
Levorphanol—Insomnia—Capecitabine—kidney cancer	0.0018	0.00182	CcSEcCtD
Levorphanol—Morphine—ABCB1—kidney cancer	0.00175	0.12	CrCbGaD
Levorphanol—Dyspepsia—Capecitabine—kidney cancer	0.00175	0.00178	CcSEcCtD
Levorphanol—Visual impairment—Doxorubicin—kidney cancer	0.00174	0.00176	CcSEcCtD
Levorphanol—Nausea—Gemcitabine—kidney cancer	0.00172	0.00174	CcSEcCtD
Levorphanol—Pruritus—Paclitaxel—kidney cancer	0.00171	0.00174	CcSEcCtD
Levorphanol—Constipation—Capecitabine—kidney cancer	0.0017	0.00172	CcSEcCtD
Levorphanol—Flushing—Doxorubicin—kidney cancer	0.00167	0.0017	CcSEcCtD
Levorphanol—Feeling abnormal—Capecitabine—kidney cancer	0.00164	0.00166	CcSEcCtD
Levorphanol—Gastrointestinal pain—Capecitabine—kidney cancer	0.00163	0.00165	CcSEcCtD
Levorphanol—Arrhythmia—Doxorubicin—kidney cancer	0.00161	0.00163	CcSEcCtD
Levorphanol—Dizziness—Paclitaxel—kidney cancer	0.0016	0.00163	CcSEcCtD
Levorphanol—Urticaria—Capecitabine—kidney cancer	0.00158	0.0016	CcSEcCtD
Levorphanol—Abdominal pain—Capecitabine—kidney cancer	0.00157	0.00159	CcSEcCtD
Levorphanol—Tension—Doxorubicin—kidney cancer	0.00154	0.00156	CcSEcCtD
Levorphanol—Vomiting—Paclitaxel—kidney cancer	0.00154	0.00156	CcSEcCtD
Levorphanol—Rash—Paclitaxel—kidney cancer	0.00153	0.00155	CcSEcCtD
Levorphanol—Dermatitis—Paclitaxel—kidney cancer	0.00153	0.00155	CcSEcCtD
Levorphanol—Nervousness—Doxorubicin—kidney cancer	0.00152	0.00155	CcSEcCtD
Levorphanol—Muscle spasms—Doxorubicin—kidney cancer	0.00151	0.00153	CcSEcCtD
Levorphanol—Dextromethorphan—ABCB1—kidney cancer	0.00147	0.101	CrCbGaD
Levorphanol—Agitation—Doxorubicin—kidney cancer	0.00144	0.00146	CcSEcCtD
Levorphanol—Nausea—Paclitaxel—kidney cancer	0.00144	0.00146	CcSEcCtD
Levorphanol—Estrone—ABCB1—kidney cancer	0.00141	0.0966	CrCbGaD
Levorphanol—Pruritus—Capecitabine—kidney cancer	0.00141	0.00143	CcSEcCtD
Levorphanol—Palpitations—Doxorubicin—kidney cancer	0.00139	0.00141	CcSEcCtD
Levorphanol—Convulsion—Doxorubicin—kidney cancer	0.00136	0.00138	CcSEcCtD
Levorphanol—Dizziness—Capecitabine—kidney cancer	0.00131	0.00133	CcSEcCtD
Levorphanol—Dry mouth—Doxorubicin—kidney cancer	0.00131	0.00133	CcSEcCtD
Levorphanol—Confusional state—Doxorubicin—kidney cancer	0.00129	0.00131	CcSEcCtD
Levorphanol—Vomiting—Capecitabine—kidney cancer	0.00126	0.00128	CcSEcCtD
Levorphanol—Shock—Doxorubicin—kidney cancer	0.00126	0.00128	CcSEcCtD
Levorphanol—Rash—Capecitabine—kidney cancer	0.00125	0.00127	CcSEcCtD
Levorphanol—Dermatitis—Capecitabine—kidney cancer	0.00125	0.00127	CcSEcCtD
Levorphanol—Tachycardia—Doxorubicin—kidney cancer	0.00125	0.00127	CcSEcCtD
Levorphanol—Hyperhidrosis—Doxorubicin—kidney cancer	0.00124	0.00126	CcSEcCtD
Levorphanol—Hypotension—Doxorubicin—kidney cancer	0.0012	0.00121	CcSEcCtD
Levorphanol—Nausea—Capecitabine—kidney cancer	0.00118	0.0012	CcSEcCtD
Levorphanol—Insomnia—Doxorubicin—kidney cancer	0.00116	0.00118	CcSEcCtD
Levorphanol—Dyspepsia—Doxorubicin—kidney cancer	0.00113	0.00114	CcSEcCtD
Levorphanol—Constipation—Doxorubicin—kidney cancer	0.0011	0.00111	CcSEcCtD
Levorphanol—Estradiol—ABCB1—kidney cancer	0.00107	0.0732	CrCbGaD
Levorphanol—Feeling abnormal—Doxorubicin—kidney cancer	0.00106	0.00107	CcSEcCtD
Levorphanol—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00105	0.00106	CcSEcCtD
Levorphanol—Urticaria—Doxorubicin—kidney cancer	0.00102	0.00103	CcSEcCtD
Levorphanol—Abdominal pain—Doxorubicin—kidney cancer	0.00101	0.00103	CcSEcCtD
Levorphanol—Pruritus—Doxorubicin—kidney cancer	0.000906	0.00092	CcSEcCtD
Levorphanol—Dizziness—Doxorubicin—kidney cancer	0.000847	0.00086	CcSEcCtD
Levorphanol—Vomiting—Doxorubicin—kidney cancer	0.000815	0.000827	CcSEcCtD
Levorphanol—Rash—Doxorubicin—kidney cancer	0.000808	0.00082	CcSEcCtD
Levorphanol—Dermatitis—Doxorubicin—kidney cancer	0.000807	0.000819	CcSEcCtD
Levorphanol—Nausea—Doxorubicin—kidney cancer	0.000761	0.000772	CcSEcCtD
